S. Alkaabi

发表

NAFLD is a predictor of liver injury in COVID-19 hospitalized patients but not of mortality, disease severity on the presentation or progression – The debate continues

Fateen Ata, Fatima Iqbal, Y. Kamel, 2020, Journal of Hepatology.

Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

N. Rizk, M. Derbala, S. Alkaabi, 2012, World journal of gastroenterology.

Acute-on-Chronic Liver Failure: Possibly the Main Culprit of Increased Mortality in COVID-19 Patients with Liver Disease

K. Mushtaq, M. Khan, S. Alkaabi, 2020, Gastroenterology.

Eradication of hepatitis C virus infection in kidney transplant recipients using direct‐acting antiviral therapy: Qatar experience

A. Butt, Awais Nauman, M. Asim, 2020, Immunity, inflammation and disease.

Risks and Rewards of Bariatric Surgery Vs Intragastric Balloon Placement: A Comparative Study at HMC Qatar

K. Al-Ejji, S. Alkaabi, K. Sultan, 2021 .

Aspartate transaminase to platelet ratio index in hepatitis C virus and Schistosomiasis coinfection.

F. Shebl, P. Chandra, Y. Kamel, 2015, World journal of gastroenterology.

Measles hepatitis in a vaccinated liver transplant recipient: case report and review of literature

M. Almaslamani, M. Derbala, S. Alkaabi, 2017, Clinical case reports.

Gene therapy for spinal muscular atrophy: the Qatari experience

T. Ben-Omran, M. Elsaid, Hossamaldein Ali, 2021, Gene Therapy.

SAFETY AND EFFECTIVENESS OF THE BNT162B2 MRNA COVID-19 VACCINE IN A NATIONWIDE COHORT OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Hafiz Younis, K. Mushtaq, M. Saddique, 2022, Gastroenterology.